Kidney Functional Clinical Trial
Official title:
GLP-1: Acute Effects on Kidney Function in Healthy Men
The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GLP-1) affects kidney function in healthy young men. The hypothesis is that GLP-1 induces a positive effect on kidney hemodynamics.
Status | Completed |
Enrollment | 12 |
Est. completion date | December 2011 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 30 Years |
Eligibility |
Inclusion Criteria: - Healthy young men Exclusion Criteria: - Any chronic diseases |
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Denmark | Klinisk Institut, Afd. MEA, Aarhus Sygehus, NBG | Aarhus C |
Lead Sponsor | Collaborator |
---|---|
Jeppe Skov | Novo Nordisk A/S |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Glomerular Filtration Rate | Every 20 minutes for 6 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02437838 -
Optimizing Drug Doses in Critically Ill
|
N/A |